×

Teva to buy Allergan Generics for $40.5B

11:40 AM ET Mon, 27 July 2015

Teva Pharmaceutical has announced plans to acquire Allergan's generic drug business for $40.5 billion. Ronny Gal, stock analyst at Sanford C. Bernstein, discusses.